There are no evidence-based guidelines about prophylaxis against Pneumocystis jiroveci pneumonia in inflammatory bowel disease. We report a case of P. jiroveci pneumonia in patient with Crohn´s disease receiving infliximab and methotrexate. This case emphasizes the importance of considering the possibility of this infection in inflammatory bowel disease patients treated on biological therapy.
|Translated title of the contribution||Pneumocystis jiroveci pneumonia following infliximab therapy in patient with Crohn´s disease|
|Number of pages||2|
|Journal||Revista Chilena de Infectologia|
|State||Published - Oct 2017|
Bibliographical notePublisher Copyright:
© 2018, Sociedad Chilena de Infectologia. All rights reserved.